Literature DB >> 21425431

Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Brian B Borg1, Anil Seetharam, Vijay Subramanian, Haseeb Ilias Basha, Mauricio Lisker-Melman, Kevin Korenblat, Christopher D Anderson, Surendra Shenoy, William C Chapman, Jeffrey S Crippin, Thalachallour Mohanakumar.   

Abstract

Hepatitis C virus (HCV) infection and its recurrence after orthotopic liver transplantation (OLT) are associated with the remodeling of extracellular matrix (ECM) components [particularly collagen (Col)], which leads to fibrosis. Our aim was to determine whether the development of antibodies (Abs) to self-antigen Col in HCV-infected patients correlates with the fibrosis stage and the peripheral cytokine response. Patients with chronic HCV infection, patients with HCV recurrence after OLT who had undergone a biopsy procedure, and healthy control subjects were enrolled. The HCV subjects (n = 70) were stratified as follows: (1) a non-OLT group without fibrosis (Scheuer stages 0-2), (2) a non-OLT group with fibrosis (Scheuer stages 3-4), (3) a post-OLT group without fibrosis (Scheuer stages 0-2), and (4) a post-OLT group with fibrosis (Scheuer stages 3-4). Serum samples were analyzed for Abs against Col1, Col2, Col4, Col5, and vimentin with enzyme-linked immunosorbent assays. Serum levels of cytokines were measured with multiplex bead immunoassays. The levels of Abs to Col1 were higher in the fibrosis groups versus the no-fibrosis groups and the controls for both non-OLT patients (P < 0.001) and post-OLT patients (P = 0.01). There were increased levels of Abs to Col2, Col4, Col5, and vimentin in the non-OLT fibrosis group (Col2, P = 0.0001; Col4, P = 0.122; Col5, P < 0.0001; vimentin, P = 0.36) and in the post-OLT fibrosis group (Col2, P = 0.006; Col4, P = 0.19; Col5, P < 0.0001; vimentin, P = 0.24) in comparison with the no-fibrosis groups. The non-OLT and post-OLT fibrosis groups demonstrated significantly higher T helper 2 (T(h) 2) and T helper 17 (T(h) 17) cytokine levels and lower T helper 1 cytokine levels in comparison with the no-fibrosis groups. Our results demonstrate that in HCV-infected patients, the levels of Abs to ECM Col1, Col2, and Col5 positively correlate with liver fibrosis, which is associated with a predominantly T(h) 2 and T(h) 17 cytokine profile.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425431      PMCID: PMC3700355          DOI: 10.1002/lt.22303

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  45 in total

1.  Enhanced expression of interleukin-6 in chronic hepatitis C.

Authors:  Y Oyanagi; T Takahashi; S Matsui; S Takahashi; S Boku; K Takahashi; K Furukawa; F Arai; H Asakura
Journal:  Liver       Date:  1999-12

2.  Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of type V collagen in liver under normal and pathological conditions.

Authors:  K K Takai; S Hattori; S Irie
Journal:  Cell Struct Funct       Date:  2001-10       Impact factor: 2.212

3.  Estimating future hepatitis C morbidity, mortality, and costs in the United States.

Authors:  J B Wong; G M McQuillan; J G McHutchison; T Poynard
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

4.  Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.

Authors:  Dilip S Nath; Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Chiraag Alur; Donna Phelan; Gregory A Ewald; Nader Moazami; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2010-07-07       Impact factor: 10.247

5.  Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses.

Authors:  C Caldas; E Luna; M Spadafora-Ferreira; G Porto; L K Iwai; S E Oshiro; S M Monteiro; J A Fonseca; F Lemos; J Hammer; P L Ho; J Kalil; V Coelho
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 6.  Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.

Authors:  G Giannelli; S Antonaci
Journal:  Histol Histopathol       Date:  2005-07       Impact factor: 2.303

7.  Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice.

Authors:  Hui-Chen Hsu; PingAr Yang; John Wang; Qi Wu; Riley Myers; Jian Chen; John Yi; Tanja Guentert; Albert Tousson; Andrea L Stanus; Thuc-vy L Le; Robin G Lorenz; Hui Xu; Jay K Kolls; Robert H Carter; David D Chaplin; Robert W Williams; John D Mountz
Journal:  Nat Immunol       Date:  2007-12-23       Impact factor: 25.606

8.  Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

Authors:  Balakrishnan Mahesh; Hon-Sing Leong; Ann McCormack; Padmini Sarathchandra; Angela Holder; Marlene L Rose
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

9.  Novel serum biomarker candidates for liver fibrosis in hepatitis C patients.

Authors:  Bevin Gangadharan; Robin Antrobus; Raymond A Dwek; Nicole Zitzmann
Journal:  Clin Chem       Date:  2007-08-16       Impact factor: 8.327

10.  Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.

Authors:  M-Y Hsieh; C-Y Dai; L-P Lee; J-F Huang; W-C Tsai; N-J Hou; Z-Y Lin; S-C Chen; L-Y Wang; W-Y Chang; W-L Chuang; M-L Yu
Journal:  J Clin Pathol       Date:  2007-06-01       Impact factor: 3.411

View more
  11 in total

1.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

2.  Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.

Authors:  Anil B Seetharam; Brian B Borg; Vijay Subramanian; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

3.  Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.

Authors:  Da Zhou; Jing Wang; Ling-Nan He; Bing-Hang Li; Yong-Nian Ding; Yuan-Wen Chen; Jian-Gao Fan
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

Review 4.  Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Nataraju Angaswamy; T Mohanakumar
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

5.  Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.

Authors:  Jingga Morry; Worapol Ngamcherdtrakul; Shenda Gu; Shaun M Goodyear; David J Castro; Moataz M Reda; Thanapon Sangvanich; Wassana Yantasee
Journal:  Biomaterials       Date:  2015-07-10       Impact factor: 12.479

6.  Detection of antibodies to self-antigens (K-alpha 1 tubulin, collagen I, II, IV, and V, myosin, and vimentin) by enzyme-linked immunosorbent assay (ELISA).

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; T Mohanakumar
Journal:  Methods Mol Biol       Date:  2013

Review 7.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

8.  A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats.

Authors:  Yang Xu; Zhangxiao Peng; Weidan Ji; Xiang Li; Xuejing Lin; Liqiang Qian; Xiaoya Li; Xiaoyun Chai; Qiuye Wu; Quangen Gao; Changqing Su
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

9.  Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.

Authors:  Chi-Jung Huang; Fa-Kung Lee; Shao-Kuan Chen; Chih-Cheng Chien; Sheng-Tang Wu; Yen-Chieh Wang
Journal:  Int J Mol Med       Date:  2017-11-17       Impact factor: 4.101

Review 10.  Extracellular Matrix in Plants and Animals: Hooks and Locks for Viruses.

Authors:  Livia Stavolone; Vincenzo Lionetti
Journal:  Front Microbiol       Date:  2017-09-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.